2018
DOI: 10.1146/annurev-micro-090817-062338
|View full text |Cite
|
Sign up to set email alerts
|

Pneumococcal Vaccines: Host Interactions, Population Dynamics, and Design Principles

Abstract: Streptococcus pneumoniae (the pneumococcus) is a nasopharyngeal commensal and respiratory pathogen. Most isolates express a capsule, the species-wide diversity of which has been immunologically classified into ∼100 serotypes. Capsule polysaccharides have been combined into multivalent vaccines widely used in adults, but the T cell independence of the antibody response means they are not protective in infants. Polysaccharide conjugate vaccines (PCVs) trigger a T cell-dependent response through attaching a carri… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
68
0
2

Year Published

2019
2019
2024
2024

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 50 publications
(70 citation statements)
references
References 200 publications
0
68
0
2
Order By: Relevance
“…The opportunistic human pathogen Streptococcus pneumoniae (the pneumococcus) kills over a million individuals each year, despite the introduction of several vaccines targeting its capsule (Croucher et al, 2018;O'Brien et al, 2009;Prina et al, 2015). Because of its ability to take up DNA from its environment by competence activation, genes associated with capsule biosynthesis are rapidly transferred from one strain to the other thereby contributing to vaccine escape (Salvadori et al, 2019).…”
Section: Introductionmentioning
confidence: 99%
“…The opportunistic human pathogen Streptococcus pneumoniae (the pneumococcus) kills over a million individuals each year, despite the introduction of several vaccines targeting its capsule (Croucher et al, 2018;O'Brien et al, 2009;Prina et al, 2015). Because of its ability to take up DNA from its environment by competence activation, genes associated with capsule biosynthesis are rapidly transferred from one strain to the other thereby contributing to vaccine escape (Salvadori et al, 2019).…”
Section: Introductionmentioning
confidence: 99%
“…Streptococcus pneumoniae is a leading cause of disease ranging from mild to severe manifestations. Invasive pneumococcal disease (IPD) includes the life-threatening conditions of bacteraemia and meningitis, both of which have high mortality rates [1,2] and S. pneumoniae is also a leading cause of pneumonia. A major virulence factor of S. pneumoniae is the polysaccharide capsule and, based on the biochemical properties of the capsule, S. pneumoniae is categorized into different serotypes.…”
Section: Introductionmentioning
confidence: 99%
“…A major virulence factor of S. pneumoniae is the polysaccharide capsule and, based on the biochemical properties of the capsule, S. pneumoniae is categorized into different serotypes. Currently, approximately 100 serotypes are known [2,3]. Several serotypes (including 7F, 14, 15B/C and 18C) have repeatedly been associated with invasive disease while other serotypes (such as 6B, 9 V, 19F and 23F) are more commonly associated with asymptomatic colonization of the human nasopharynx [1,[4][5][6][7].…”
Section: Introductionmentioning
confidence: 99%
“…23-valent polysaccharide vaccine and polyvalent glycoconjugate vaccines) are based on the capsular polysaccharide. The introduction of pneumococcal vaccines has led to a decrease in the prevalence of vaccine serotypes (Croucher et al, 2018). The replacement of serotypes that are a part of current pneumococcal vaccines with nonvaccine serotypes has been reported (Ciruela et al, 2018;Sakata et al, 2018;Usuf et al, 2018).…”
Section: Introductionmentioning
confidence: 99%